Unleashing Innovation: The Case for Permissionless R&D in Pharma

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - A podcast by DrugPatentWatch - Fridays

Categories:

Business

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior… Source